Physician profile
Ellen Jane Moore
NPI 1912226960
$670.58
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $70.47 · 2021: $88.92 · 2022: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $101.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $79.50 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $74.48 | 2019-2020 | |
| Amgen INC. | $56.68 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.08 | 2019-2022 | |
| Bausch Health US, LLC | $44.38 | 2019 | |
| Pfizer INC. | $42.23 | 2019 | |
| Lilly USA, LLC | $37.61 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.17 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $28.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.49 | 2019-2020 | |
| Allergan, INC. | $18.25 | 2020 | |
| Glaxosmithkline, LLC. | $16.82 | 2019 | |
| Boston Scientific Corporation | $13.07 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $11.75 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.